Clinical Trial Update: Trial of Mifepristone in Combat Veterans With Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mifepristone for combat-related posttraumatic stress disorder; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: UNKNOWN